An Update on ICU Management of the Potential Organ Donor

  • M. T. Keegan
  • K. E. Wood
  • D. B. Coursin

Abstract

Solid organ transplantation was one of the great advances in medicine in the 20th century. Indications and demand for transplantation have, however, led to a chronic shortage of transplantable organs. Although donation rates have increased over the past decade, many patients die while waiting for a transplant [1]. In September 2009, there were 103,000 patients awaiting transplantation in the United States [2]. The development of artificial organs continues, but in the short to medium term the medical community will continue to rely on organs retrieved from recently-deceased patients. The majority of organs are procured from patients who have suffered a devastating neurologic injury and have progressed to brainstem death. In recent years, programs have been developed to allow organ donation after cardiac death, though such donors account for less than 10 % of all organs transplanted. Unfortunately, many individuals who satisfy criteria for becoming organ donors fail to donate, mainly because of lack of consent [3]. In others, a suboptimal number of organs are recovered. The greatest discrepancy between supply and demand exists for lungs and only 7–22 % of multiple-organ donors are deemed suitable to become lung donors. (Non-conversion' occurs for two main reasons: In 10–20 % of cases, the patient succumbs to somatic death (i.e., cardiac arrest) after brainstem death but before organs can be retrieved [4]; in other cases, organs are deemed unsuitable for donation because of their condition. ‘Optimization’ of such organs has been the focus of initiatives by organ procurement organizations. The Organ Donation and Transplantation Breakthrough Collaborative, the latest initiative of the United States Health Resources and Service Administration, seeks to meet the goals of 3.75 organs transplanted per donor and a 75 % conversion rate for all potential organ donors.

Keywords

Starch Ischemia Dopamine Epinephrine Catecholamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sung RS, Galloway J, Tuttle-Newhall JE, et al (2008) Organ donation and utilization in the United States, 1997–2006. Am J Transplant 8: 922–934CrossRefPubMedGoogle Scholar
  2. 3.
    Sheehy E, Conrad SL, Brigham LE, et al (2003) Estimating the number of potential organ donors in the United States. N Engl J Med 349: 667–674CrossRefPubMedGoogle Scholar
  3. 4.
    Grossman M, Reilly P, McMahon D (1996) Loss of potential organ donors due to medical failure. Crit Care Med 24: A76 (abst)CrossRefGoogle Scholar
  4. 5.
    HRSA Transplant Center Growth and Management Collaborative (2007) Best Practices Evaluation Final Report-September 2007. Available at: http://www.organdonor.gov/research/best_ practiceslIntroduction.htm Accessed Dec 2009Google Scholar
  5. 6.
    Smith M (2004) Physiologic changes during brain stem death—Iessons for management of the organ donor. J Heart Lung Transplant 23: S217–222CrossRefPubMedGoogle Scholar
  6. 7.
    Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB (2004) Care of the potential organ donor. N Engl J Med 351: 2730–2739CrossRefPubMedGoogle Scholar
  7. 8.
    Wood KE, Coursin DB (2007) Intensivists and organ donor management. Curr Opin Anesthesiol 20: 97–99CrossRefGoogle Scholar
  8. 9.
    Szabo G (2004) Physiologic changes after brain death. J Heart Lung Transplant 23: S223–226CrossRefPubMedGoogle Scholar
  9. 10.
    Rosendale JD, Chabalewski FL, McBride MA, et al (2002) Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2: 761–768CrossRefPubMedGoogle Scholar
  10. 15.
    Zaroff JG, Rosengard BR, Armstrong WF, et al (2002) Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28–29, 2001, Crystal City, Va. Circulation 106: 836–841CrossRefPubMedGoogle Scholar
  11. 16.
    Rosengard BR, Feng S, Alfrey EJ, et al (2002) Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2: 701–711CrossRefPubMedGoogle Scholar
  12. 17.
    Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD (2006) Medical management to optimize donor organ potential: review of the literature. Can J Anaesth 53: 820–830CrossRefPubMedGoogle Scholar
  13. 18.
    Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M (2009) Management to optimize organ procurement in brain-dead donors. Minerva Anestesiol 75: 125–133PubMedGoogle Scholar
  14. 19.
    Wood K, McCartney J (2007) Management of the potential organ donor. Transplant Rev 21: 204–218CrossRefGoogle Scholar
  15. 20.
    Lytle FT, Afessa B, Keegan MT (2009) Progression of organ failure in patients approaching brain stem death. Am J Transplant 9: 1446–1450CrossRefPubMedGoogle Scholar
  16. 21.
    Cittanova ML, Leblanc I, Legendre C, et al (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348: 1620–1622CrossRefPubMedGoogle Scholar
  17. 22.
    Marshall R, Ahsan N, Dhillon S, Holman M, Yang HC (1996) Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function. Surgery 120: 663–665CrossRefPubMedGoogle Scholar
  18. 23.
    Schnuelle P, Lorenz D, Mueller A, Trede M, Van Der Woude FJ (1999) Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 56: 738–746CrossRefPubMedGoogle Scholar
  19. 24.
    Venkateswaran RV Steeds RP, Quinn DW, et al (2009) The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J 30: 1771–1780CrossRefPubMedGoogle Scholar
  20. 25.
    Kono T, Nishina T, Morita H, et al (2006) Usefulness of low-dose dobutamine stress echo cardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol 84: 578–582CrossRefGoogle Scholar
  21. 26.
    Powner DJ, Allison TA (2006) Cardiac dysrhythmias during donor care. Prog Transplant 16: 74–80PubMedGoogle Scholar
  22. 28.
    Botha P, Rostron AJ, Fisher AJ, Dark JH (2008) Current strategies in donor selection and management. Semin Thorac Cardiovasc Surg 20: 143–151CrossRefPubMedGoogle Scholar
  23. 29.
    Van Raemdonck D, Neyrinck A, Verleden GM, et al (2009) Lung donor selection and management. Proc Am Thoracic Soc 6: 28–38CrossRefGoogle Scholar
  24. 30.
    Novitzky D, Wicomb WN, Rose AG, Cooper DK, Reichart B (1987) Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon. Ann Thorac Surg 43: 288–294CrossRefPubMedGoogle Scholar
  25. 31.
    Koutsoukou A, Perraki H, Raftopoulou A, et al (2006) Respiratory mechanics in brain-damaged patients. Intensive Care Med 32: 1947–1954CrossRefPubMedGoogle Scholar
  26. 32.
    Fisher AJ, Donnelly SC, Hirani N, et al (1999) Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 353: 1412–1413CrossRefPubMedGoogle Scholar
  27. 33.
    McKeating EG, Andrews PJ, Signorini DF, Mascia L (1997) Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 78: 520–523PubMedGoogle Scholar
  28. 34.
    Gabbay E, Williams TJ, Griffiths AP, et al (1999) Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160: 265–271PubMedGoogle Scholar
  29. 35.
    Angel LF, Levine DJ, Restrepo MI, et al (2006) Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 174: 710–716CrossRefPubMedGoogle Scholar
  30. 36.
    Venkateswaran RV Dronavalli V, Lambert PA, et al (2009) The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. Transplantation 88: 582–588CrossRefPubMedGoogle Scholar
  31. 37.
    Dimopoulou I, Tsagarakis S (2005) Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury. Intensive Care Med 31: 1020–1028CrossRefPubMedGoogle Scholar
  32. 38.
    Cooper DK, Novitzky D, Wicomb WN, et al (2009) A review of studies relating to thyroid hormone therapy in brain-dead organ donors. Front Biosci 14: 3750–3770CrossRefPubMedGoogle Scholar
  33. 39.
    Gores PF, Gillingham KJ, Dunn DL, et al (1992) Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution’s experience. Ann Surg 215: 217–230CrossRefPubMedGoogle Scholar
  34. 40.
    Schnuelle P, Gottman U, Hoeger S, et al (2009) Effects of donor pretreatment with dopamine on graft function after kidney transplantation. JAMA 302: 1067–1075CrossRefPubMedGoogle Scholar
  35. 41.
    Totsuka E, Dodson F, Urakami A, et al (1999) Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg 5: 421–428CrossRefPubMedGoogle Scholar
  36. 42.
    Steven M, Pace N (2003) Non-heart-beating organ donation. Eur J Anaesthesiol 20: 855–858CrossRefPubMedGoogle Scholar
  37. 43.
    Reich DJ, Mulligan DC, Abt PL, et al (2009) ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. Am J Transplant 9: 2004–2011CrossRefPubMedGoogle Scholar
  38. 44.
    Bernat JL, D'Alessandro AM, Port FK, et al (2006) Report of a National Conference on Donation after cardiac death. Am J Transplant 6: 281–291CrossRefPubMedGoogle Scholar
  39. 45.
    Truog RD, Robinson WM. (2003) Role of brain death and the dead-donor rule in the ethics of organ transplantation. Crit Care Med 31: 2391–2396CrossRefPubMedGoogle Scholar
  40. 46.
    Ethics Committee, American College of Critical Care Medicine, Society of Critical Care Medicine (2001) Recommendations for nonheartbeating organ donation. A position paper. Crit Care Med 29: 1826–1831CrossRefGoogle Scholar
  41. 47.
    Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA (2002) Kidney transplantation from donors without a heartbeat. N Engl J Med 347: 248–255CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2010

Authors and Affiliations

  • M. T. Keegan
    • 1
  • K. E. Wood
    • 2
  • D. B. Coursin
    • 2
  1. 1.Mayo Clinic College of MedicineRochesterUSA
  2. 2.Department of Anesthesiology and MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations